Evidence map›Paper›PMID 24378774›Full record

ReviewCurrent opinion in nephrology and hypertension2014

Renal angiotensin-converting enzyme and blood pressure control.

Kenneth E Bernstein, Jorge F Giani, Xiao Z Shen, Romer A Gonzalez-Villalobos

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in nephrology and hypertension, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Saudi journal of biological sciences · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Hepatic and renal mechanisms underlying the osmopressor response.Autonomic neuroscience : basic & clinical · 2017
    Article
  15. Review
  16. Article
  17. Association of ACE polymorphism and diabetic nephropathy susceptibility.International journal of clinical and experimental medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kenneth E BernsteinDepartments of Biomedical Sciences and Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Jorge F Giani
Xiao Z Shen
Romer A Gonzalez-Villalobos
Cedars-Sinai Medical Center · US

Funding

RAS and InjuryR01HL110353 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI BERNSTEIN, KENNETH E · 2011 to 2015
$2.2M
RENIN/ANGIOTENSIN SYSTEM AND INJURYR01DK039777 · NIDDK · EMORY UNIVERSITY · PI BERNSTEIN, KENNETH E · 1988 to 2010
$1.3M
Intrarenal Angiotensin II generation during Angiotensin II-induced hypertensionR00DK083455 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI GONZALEZ-VILLALOBOS, ROMER ANDRES · 2011 to 2013
$720k
NHLBI NIH HHS R01 HL110353NHLBI NIH HHS R01HL110353NIDDK NIH HHS R00 DK083455NIDDK NIH HHS R00DK083455NIDDK NIH HHS R01 DK039777
6 · The paper itself

Abstract

purpose of reviewThis review presents novel findings regarding the renal angiotensin-converting enzyme (ACE) and its role in blood pressure (BP) control. RECENT

findingsThe textbook flow diagram of the renin-angiotensin system (RAS) shows the pulmonary endothelium as the main source of the ACE that converts angiotensin I to angiotensin II. However, ACE is made in large quantities by the kidneys, which raises the important question of what precisely is the function of renal ACE? Recent studies in gene-targeted mice indicates that renal ACE plays a dominant role in regulating the response of the kidney to experimental hypertension. In particular, renal ACE and locally generated angiotensin II affect the activity of several key sodium transporters and the induction of sodium and water retention resulting in the elevation of BP. SUMMARY: New experimental data link the renal ACE/angiotensin II pathway and the local regulation of sodium transport as key elements in the development of hypertension.

Indexed as

Blood PressureRenin-Angiotensin SystemAngiotensin IIAnimalsBody WaterHumansHypertensionKidneyPeptidyl-Dipeptidase ASignal TransductionSodiumWater-Electrolyte BalanceWater-Electrolyte ImbalanceACE protein, humanAngiotensin IIPeptidyl-Dipeptidase ASodium

Identifiers

PMID24378774
PMCPMC4028050
OpenAlexW1974919829

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.